Latest Safety News

Duratec Limited (ASX:DUR) reported a 4.1% rise in net profit after tax to $23.8 million for FY26 on stable revenue, underpinned by a record $650.8 million order book and multiple strategic acquisitions expanding its service portfolio.

Metallium has resolved a key permitting constraint at its Texas Gator Point campus, enabling chlorinated Flash Joule Heating testing to resume ahead of a major September campaign. The company also marks first revenue from its MXene development program and strengthens engineering leadership.

Sandfire Resources Ltd (ASX:SFR) posted a 41% revenue jump to $1.65 billion and a 282% surge in net profit to $355.8 million for FY26, driven by strong operational performance and robust commodity prices. The company declared a fully franked 35 Australian cents per share dividend and advanced its Kalkaroo Copper-Gold Project with a $70 million pre-feasibility study underway.

Veris Limited lifted revenue by 4.9% to $102 million in FY26, driven by digital and advisory growth, but statutory net profit fell 67% amid one-off costs and macroeconomic headwinds.

Scott Technology aims to more than double Protein Domain revenue to NZ$165 million by FY30, leveraging global growth of its BladeStop safety bandsaw and a new Mexico distribution deal.

Neurizon Therapeutics has completed enrolment in its pivotal HEALEY ALS Platform Trial ahead of schedule, secured critical manufacturing and funding agreements, and reduced its net loss for FY2026 while preparing for topline results in late Q2 2027.

K&S Corporation’s FY2026 profit fell 16% underlying, with a 31% dividend cut reflecting cautious outlook amid economic uncertainty and contract losses.

Prescient Therapeutics launches a $7 million Share Purchase Plan at an 18.8% discount to fund advancement of its PTX-100 cancer therapy beyond a key 2026 Dose Optimisation Committee review.

Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals secured European Commission approval for DAYBU (trofinetide) to treat Rett syndrome symptoms in patients aged five and older, marking the first EU-authorised treatment for this condition.

Acusensus posted a 45% jump in FY26 revenue to $86.2 million, driven by major contract wins in New Zealand and the US, alongside robust domestic expansions. Despite a widened net loss due to a $16 million litigation settlement, adjusted EBITDA climbed 49%, reflecting operational momentum and strategic investments.

Woodside Energy delivered a strong first half in 2026, with revenue up 13% to $7.45 billion, net profit after tax reaching $1.67 billion, and key LNG and oil projects advancing on schedule. The company declared a fully franked interim dividend of 57 US cents per share amid ongoing global market volatility.

Big River Industries (ASX:BRI) reversed a $14.8 million loss in FY25 to a $4.9 million profit in FY26, driven by margin expansion and the acquisition of Johns Building Supplies. The group targets double-digit EBITDA growth in FY27 amid mixed market conditions.